Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 201-250 of 672 result(s).
CYDY CytoDyn Inc
03/05/2021 1:24:41 PM
No just referencing NP who describe (2)
CYDY CytoDyn Inc
03/05/2021 12:30:37 PM
I hope that communication did not v (5)
CYDY CytoDyn Inc
03/04/2021 7:28:01 PM
Yes the study cited on the board wa
CYDY CytoDyn Inc
03/01/2021 4:35:11 PM
Does anyone have an opinion why the (1)
CYDY CytoDyn Inc
02/26/2021 2:31:13 PM
Sorry, although I thought people ha (2)
CYDY CytoDyn Inc
02/26/2021 2:06:31 PM
They are not scrambling: The clinic (5)
CYDY CytoDyn Inc
02/26/2021 12:31:53 PM
Exactly, IMO they are scrambling to (2)
CYDY CytoDyn Inc
02/25/2021 4:03:39 PM
Exactly they may have NOT followed
CYDY CytoDyn Inc
02/25/2021 4:01:08 PM
I agree but CYDY has no R&D.
CYDY CytoDyn Inc
02/25/2021 2:07:07 PM
I will give an example, if a patien
CYDY CytoDyn Inc
02/25/2021 2:01:59 PM
I think the data will be strong, ju
CYDY CytoDyn Inc
02/25/2021 1:44:50 PM
Just my thoughts: NP's statement of (1)
CYDY CytoDyn Inc
02/24/2021 4:45:59 PM
Depends on trial design.
CYDY CytoDyn Inc
02/23/2021 10:18:40 PM
Hopefully if all data points were f
CYDY CytoDyn Inc
02/23/2021 4:45:30 PM
Well I am not one to engage in pred
CYDY CytoDyn Inc
02/23/2021 4:08:04 PM
You are absolutely right, patients (2)
CYDY CytoDyn Inc
02/23/2021 3:26:26 PM
They never said "should" simply the (1)
CYDY CytoDyn Inc
02/23/2021 3:22:11 PM
The communication came from the FDA (3)
CYDY CytoDyn Inc
02/23/2021 3:05:13 PM
Sorry RLF changed their endpoint in
CYDY CytoDyn Inc
02/23/2021 3:00:12 PM
Those were not my words to be clear
CYDY CytoDyn Inc
02/23/2021 2:52:25 PM
My posts tend to be misunderstood: (4)
CYDY CytoDyn Inc
02/23/2021 12:50:03 PM
They changed it not for arsenic but
CYDY CytoDyn Inc
02/23/2021 11:58:51 AM
I know other companies are not to b (1)
CYDY CytoDyn Inc
02/23/2021 12:17:38 AM
he FDA just published updated guida (10)
CYDY CytoDyn Inc
02/21/2021 4:40:46 PM
That was Makary's point the recover (2)
CYDY CytoDyn Inc
02/21/2021 11:08:04 AM
https://www.wsj.com/articles/well- (2)
CYDY CytoDyn Inc
02/20/2021 1:54:04 PM
We had three concurrent trials, cou (3)
CYDY CytoDyn Inc
02/20/2021 7:46:20 AM
Great!
CYDY CytoDyn Inc
02/19/2021 3:53:53 PM
BTW if we are working on 80 indicat
CYDY CytoDyn Inc
02/19/2021 3:47:25 PM
I am sorry if it seemed rude but me (2)
CYDY CytoDyn Inc
02/19/2021 3:30:05 PM
I retired because I suffered a sub-
CYDY CytoDyn Inc
02/19/2021 1:37:09 PM
There may be a problem with the FP, (1)
CYDY CytoDyn Inc
02/19/2021 11:27:50 AM
Does it matter, the analogy stands, (1)
CYDY CytoDyn Inc
02/19/2021 11:22:29 AM
I agree, wasn't it Jim Jones who ga (1)
CYDY CytoDyn Inc
02/16/2021 10:12:56 AM
If the assay has 90% predictive val (7)
CYDY CytoDyn Inc
02/16/2021 8:25:39 AM
Absolutely correct, also I thought (2)
CYDY CytoDyn Inc
02/16/2021 8:17:17 AM
Remember every S/C patient started (6)
CYDY CytoDyn Inc
02/15/2021 11:25:35 PM
That is why an accurate assay with (2)
CYDY CytoDyn Inc
02/15/2021 11:19:42 PM
Then did not "have to" most of us t (2)
CYDY CytoDyn Inc
02/15/2021 7:51:22 PM
Mortality was not the PE (2)
CYDY CytoDyn Inc
02/13/2021 11:01:29 PM
I can't remember which one but beca
CYDY CytoDyn Inc
02/12/2021 7:29:56 PM
One of the best mentors I had said
CYDY CytoDyn Inc
02/12/2021 5:31:57 PM
That is Dr BP’s theory I guess as (1)
CYDY CytoDyn Inc
02/12/2021 10:35:00 AM
Dr. BP also thinks there could be a
CYDY CytoDyn Inc
02/11/2021 11:50:15 AM
FDA may wish to ascertain if there
CYDY CytoDyn Inc
02/10/2021 5:45:33 PM
Day 60
CYDY CytoDyn Inc
02/08/2021 4:25:30 PM
I suggested that if a stop gap sell
CYDY CytoDyn Inc
02/08/2021 3:50:31 PM
The only problem will be if insuran (1)
CYDY CytoDyn Inc
02/05/2021 11:14:57 PM
I hate to say I am very impressed w (2)
CYDY CytoDyn Inc
02/05/2021 7:40:07 PM
His work product will be similar to (4)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Understanding the Current State of Job Growth and Economic Change
  • Xcel Brands Secures $2.6 Million Through Recent Offering
  • LPL Financial Solidifies Market Position with Major Acquisition
  • Apple's AI Revolution: The Future of Tech and Investment
  • APTIM Secures Key Contract for Environmental Remediation Services
  • Exciting News as The Ranfurly Mysteries Series Moves Forward
  • Rocket Pharmaceuticals Faces Legal Challenges After Stock Plunge
  • Understanding Regulated Asset Base Rate of Return for KN Energies
  • Zscaler's Strategic Move with Red Canary for Advanced Security
  • Insight into Rathbones Group's Position on Primary Health Properties
  • Colgate-Palmolive: Strategic Growth Amid Restructuring Efforts
  • Explore Top Health Care Dividend Stocks for Steady Income
  • Amber Grid Secures Long-Term Financing for Growth Initiatives
  • JPMorgan Asset Management Reports Major Shareholding Changes
  • Sunrise Capital Expands Portfolio with Bourse Parking Acquisition
  • Rathbones Group Proves Its Influence in Tritax Big Box REIT
  • Lennar Launches New Home Community in New Port Corners, FL
  • Carlsmed's Innovative Implants Gain NTAP Approval for Cervical Use
  • Rev. Dr. Suzan Johnson Cook Advocates for Freedom Plaza's Vision
  • EPSO-G Enhances Financial Stability with Long-Term Loan Shift
  • Navigating Tesla's Stock: Buy Now or Wait It Out?
  • Banco Sabadell Partners with DXC for Inclusive AI Testing
  • Comprehensive Overview of Unite Group Plc's Recent Disclosures
  • Strategy Guide for Trading SPY and Leading Tech Stocks
  • DoubleLine Credit Fund Announces New Distribution Details
  • Key Updates for 3D Systems Corporation Investors and Stakeholders
  • ADMA Biologics: Understanding Market Sentiment and Trends
  • Understanding Warehouse REIT Plc's Latest Position Disclosure
  • Middlesex-London Paramedic Service Enhances Operations with ImageTrend
  • Exploring Recent Short Interest Trends for JD.com Stocks
  • Hudson RPO Strengthens Brand Engagement with CMRG Integration
  • Velo3D to Release Q2 2025 Financial Results and Insights
  • Understanding AMD Market Support: Trends in Short Interest
  • JD Martin Companies and Partners Unite to Enhance Offerings
  • e.l.f. Beauty's Future: Navigating the Uncertainty Ahead
  • BioMarin Welcomes Ian T. Clark to Its Board of Directors
  • SiMa.ai Secures $85 Million for Accelerated Global AI Growth
  • Velo3D to Share Q2 2025 Performance Insights on Earnings Call
  • Earthworks Industries Faces Court Challenge Over Lease Issues
  • Enhancing Video Creation: Insta360's New Strava Integration
  • Action Needed for Shareholders of Reckitt Benckiser Group plc
  • Leadership Change at Independence Pet Holdings Enhances Expertise
  • Kootenay Silver Unveils New Mineral Resource Estimate at Columba
  • Regard Magazine Features Yousuf Nabi in Winter Edition
  • Char Heimbach Elevated to Partner at Vic Feazell Law Offices
  • David Bang Takes the Helm as CEO for Americas at LX Pantos
  • Massage Envy Celebrates Scholarship Winners for Massage Therapists
  • AI Disruption and the Future of Digital Advertising
  • Rev. Dr. Ambassador Suzan Johnson Cook Advocates for Freedom Plaza
  • Embracing Wellness: National Wellness Month Celebration Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site